29/06/2026 17:32
|
Medical, Health & Aged Care
* Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24
* Phase 1 and Phase 3...